We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+12.15%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$121B
AUM Growth
+$4.67B
(+4%)
Cap. Flow
-$5.12B
Cap. Flow
% of AUM
-4.23%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
317
New
11
Increased
63
Reduced
194
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONC
BeOne Medicines Ltd
ONC
|
+$380M |
| 2 |
Baidu
BIDU
|
+$159M |
| 3 |
BioNTech
BNTX
|
+$97.1M |
| 4 |
XPeng
XPEV
|
+$83.7M |
| 5 |
FedEx
FDX
|
+$80.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$708M |
| 2 |
Qiagen
QGEN
|
+$562M |
| 3 |
Tesla
TSLA
|
+$465M |
| 4 |
Microsoft
MSFT
|
+$426M |
| 5 |
Qualcomm
QCOM
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.73% |
| 2 | Healthcare | 29.17% |
| 3 | Industrials | 12.07% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Financials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$1.02T
| $5.62B | 4.64% |
37,975,324
-1,652,633
| -4% | -$256M |
|
|
2
Adobe
ADBE
$93.3B
| $4.65B | 3.84% |
9,479,580
-1,522,708
| -14% | -$708M |
|
|
3
Microsoft
MSFT
$2.99T
| $4.6B | 3.8% |
21,879,289
-2,027,119
| -8% | -$426M |
|
4
Biogen
BIIB
$29.5B
| $4.45B | 3.67% |
15,696,704
+64,772
| +0.4% | +$18.1M |
|
5
Amgen
AMGN
$197B
| $4.42B | 3.65% |
17,407,082
-555,848
| -3% | -$138M |
|
6
Alibaba
BABA
$288B
| $3.77B | 3.11% |
12,814,606
-397,320
| -3% | -$105M |
|
7
Texas Instruments
TXN
$259B
| $3.58B | 2.95% |
25,054,223
-1,301,070
| -5% | -$177M |
|
|
8
FedEx
FDX
$73.1B
| $3.52B | 2.9% |
13,986,639
+403,600
| +3% | +$80.7M |
|
9
AstraZeneca
AZN
$255B
| $2.82B | 2.33% |
25,749,031
-1,081,838
| -4% | -$120M |
|
10
Southwest Airlines
LUV
$23.6B
| $2.53B | 2.09% |
67,539,448
-1,650,650
| -2% | -$58.6M |
|
11
Sony
SONY
$124B
| $2.42B | 2% |
157,882,395
-7,014,380
| -4% | -$109M |
|
12
Micron Technology
MU
$977B
| $2.37B | 1.95% |
50,407,509
-1,057,170
| -2% | -$51.2M |
|
|
13
Tesla
TSLA
$1.39T
| $2.27B | 1.87% |
15,842,325
-3,935,400
| -20% | -$465M |
|
14
Alphabet (Google) Class A
GOOGL
$4.3T
| $2.25B | 1.85% |
30,650,220
-2,067,140
| -6% | -$157M |
|
|
15
Qualcomm
QCOM
$180B
| $2.08B | 1.71% |
17,646,283
-3,538,550
| -17% | -$378M |
|
16
Thermo Fisher Scientific
TMO
$196B
| $2.03B | 1.68% |
4,598,241
-142,200
| -3% | -$58.7M |
|
17
Novartis
NVS
$285B
| $1.96B | 1.62% |
22,570,940
-696,330
| -3% | -$60.3M |
|
|
18
Alphabet (Google) Class C
GOOG
$4.29T
| $1.88B | 1.55% |
25,566,000
-2,750,460
| -10% | -$210M |
|
19
KLA
KLAC
$271B
| $1.87B | 1.54% |
96,264,890
-3,788,000
| -4% | -$74.9M |
|
20
JPMorgan Chase
JPM
$901B
| $1.59B | 1.31% |
16,533,380
-815,110
| -5% | -$80M |
|
21
Boston Scientific
BSX
$65.1B
| $1.55B | 1.28% |
40,478,915
-1,202,990
| -3% | -$46.4M |
|
22
BioMarin Pharmaceuticals
BMRN
$11.4B
| $1.38B | 1.14% |
18,191,541
+307,570
| +2% | +$31.1M |
|
23
Ericsson
ERIC
$31.7B
| $1.35B | 1.11% |
123,879,882
-1,927,090
| -2% | -$21.3M |
|
24
Intel
INTC
$488B
| $1.32B | 1.09% |
25,422,761
+779,300
| +3% | +$40.5M |
|
25
NetApp
NTAP
$31.6B
| $1.28B | 1.05% |
29,121,858
-605,080
| -2% | -$26.4M |
|
Similar funds
Primecap Management's Q3 2020 Portfolio in Review
As of Q3 2020, Primecap Management held 317 positions worth $121B, up 4% from $117B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $5.12B in Q3 2020, closing 6 positions and reducing 194 holdings. Its most notable exit was Qiagen, an estimated $562M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in XPeng worth $85.9M.
- Primecap Management's largest Q3 2020 buy was XPeng: 4,278,700 shares worth $85.9M.
- Primecap Management added most to BeOne Medicines Ltd in Q3 2020, an estimated $380M increase.
- Primecap Management's biggest Q3 2020 reduction was Adobe, cutting an estimated $708M.
- Primecap Management fully exited Qiagen in Q3 2020, selling an estimated $562M.
- Primecap Management's ten largest holdings make up 33% of its $121B portfolio in Q3 2020.
- Primecap Management opened 11 new positions and closed 6 in Q3 2020.
- Primecap Management's portfolio value rose 4% quarter-over-quarter to $121B.
Based on Primecap Management's 13F filing for Q3 2020, filed 13 Nov 2020.